Expansion of the QARS deficiency phenotype with report of a family with isolated supratentorial brain abnormalities
We describe a family with QARS deficiency due to compound heterozygous QARS mutations, including c.1387G > A (p.R463*) in the catalytic core domain and c.2226C > G (p.Q742H) in the anticodon domain, both previously unreported and predicted damaging. The phenotype of the male index further confirms this specific aminoacyl-transfer RNA (tRNA) synthetase disorder as a novel genetic cause of progressive microcephaly with diffuse cerebral atrophy, severely deficient myelination, intractable seizures, and developmental arrest. However, in contrast to the two hitherto published families, the cerebellum and its myelination are not affected. An awareness that QARS mutations may cause isolated supratentorial changes is crucial for properly directing genetic analysis.
KeywordsEpilepsy Microcephaly Developmental delay Hypomyelination Cerebral atrophy Genomics
- 1.Zhang X, Ling J, Barcia G, Jing L, Wu J, Barry BJ, Mochida GH, Hill RS, Weimer JM, Stein Q et al (2014) Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures. Am J Hum Genet 94:547–558CrossRefPubMedCentralPubMedGoogle Scholar
- 3.Perona JJ (2000) Glutaminyl-tRNA Synthetases. In: Madam Curie Science Database. Austin (TX): Landes Bioscience; (http://www.ncbi.nlm.nih.gov/books/NBK6506/)